Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DanDrit Biotech USA

DanDrit Biotech USA?uq=2zON1W4M
2001 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of a research-based pharmaceutical services intended to discover, develop, manufacture and market prescription medicines. The company's services include managing a product portfolio that includes medicines and vaccines as well as consumer healthcare products, maintaining a pipeline of new products with applications for diseases ranging from Alzheimer's to cancer, enabling pharmaceutical companies to make drugs for treatment of colorectal cancer.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Enochian Biopharma
Former Stock Listing
ENOB
Primary Office
  • 375 Park Avenue
  • Suite 2607
  • New York, NY 10152
  • United States

DanDrit Biotech USA Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore DanDrit Biotech USA‘s full profile, request access.

Request full access to PitchBook

DanDrit Biotech USA Executive Team (1)

Name Title Board
Seat
Contact
Info
Eric Leire MD Chief Executive Officer & Director